Version 5.4
Homo sapiens Protein: ATF2
Summary
InnateDB Protein IDBP-293531.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol ATF2
Protein Name activating transcription factor 2
Synonyms CRE-BP1; CREB-2; CREB2; HB16; TREB7;
Species Homo sapiens
Ensembl Protein ENSP00000386326
InnateDB Gene IDBG-75609 (ATF2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 387 experimentally validated interaction(s) in this database.
They are also associated with 18 interaction(s) predicted by orthology.
Experimentally validated
Total 387 [view]
Protein-Protein 235 [view]
Protein-DNA 152 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 18 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003700 sequence-specific DNA binding transcription factor activity
GO:0043565 sequence-specific DNA binding
GO:0046872 metal ion binding
Biological Process
GO:0006355 regulation of transcription, DNA-templated
Cellular Component
GO:0005634 nucleus
Protein Structure and Domains
PDB ID
InterPro IPR004827 Basic-leucine zipper domain
IPR007087 Zinc finger, C2H2
IPR016378 Transcription factor, cyclic AMP-dependent
PFAM PF00170
PF07716
PF00096
PRINTS
PIRSF PIRSF003153
SMART SM00338
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL B8ZZU6
UniProt Splice Variant
Entrez Gene 1386
UniGene Hs.714996
RefSeq
HUGO HGNC:784
OMIM 123811
CCDS
HPRD 00443
IMGT
EMBL AC007435 AC074291 AC096649 AC131958
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca